肌炎相关重症间质性肺病的预后与治疗:日本全国住院数据库描述性研究
结果显示住院死亡率极高,DM组显著高于PM组(76.6% vs 56.8%,P<0.001),尽管积极使用钙调磷酸酶抑制剂、环磷酰胺和PMX-DHP等治疗。
要点
- 肌炎相关重症ILD需机械通气者住院死亡率极高,DM组达76.6%。
- DM患者较PM患者更年轻(64 vs 68岁,P<0.001)且死亡率更高。
- 钙调磷酸酶抑制剂(73.4%)、静脉环磷酰胺(57.9%)和PMX-DHP(14.2%)使用较频繁。
核心结论
- 肌炎相关重症ILD需机械通气患者尽管接受积极迅速干预,死亡率仍极高。
- DM患者住院死亡率显著高于PM患者(76.6% vs 56.8%,P<0.001)。
研究设计与样本
- 回顾性描述性研究,使用日本全国急性病住院数据库。
- 共纳入155例PM和394例DM患者,中位年龄65岁。
主要发现
- DM患者显著年轻于PM患者(中位64 vs 68岁,P<0.001)。
- 钙调磷酸酶抑制剂、静脉环磷酰胺和PMX-DHP使用率分别为73.4%、57.9%和14.2%,DM组均显著高于PM组。
- DM患者住院期间甲泼尼龙冲击、钙调磷酸酶抑制剂、机械通气、静脉环磷酰胺、PMX-DHP启动及住院死亡的中位时间分别为2、4、7、8、17和36天。
- 住院死亡率DM组76.6%,PM组56.8%(P<0.001)。
关键数值与推荐
- 重症ILD定义为需机械通气并接受甲泼尼龙冲击治疗(≥1g/日)。
- 纳入PM或DM相关ILD患者,排除其他原因。
临床怎么用
- 对肌炎相关重症ILD需机械通气患者应警惕极高死亡风险,尤其DM患者。
- 尽管积极联合免疫抑制和PMX-DHP治疗,预后仍差,需探索更有效策略。
局限性
- 回顾性描述性研究,仅基于日本全国住院数据库,可能存在编码偏倚。
- 未报告具体死因、长期预后及治疗疗效比较。
- 仅纳入需机械通气的重症患者,结果不能外推至所有肌炎相关ILD。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to determine the prognosis, clinical course, and current management of severe interstitial lung disease (ILD) associated with myositis in Japan. METHODS: We conducted a retrospective descriptive study using a nationwide database for inpatient care of acute illness in Japan. Among a total of ~66 million inpatient admissions, we identified patients with severe ILD associated with polymyositis (PM) or dermatomyositis (DM) who required mechanical ventilation and methylprednisolone pulse therapy (≥1 gm/day of methylprednisolone) from July 2010 to March 2018. RESULTS: We identified 155 patients with PM and 394 with DM who fulfilled the above criteria. The median age of patients was 65 years; DM patients were significantly younger than PM patients (64 versus 68 years; P < 0.001). The numbers of patients who were treated with calcineurin inhibitors, intravenous cyclophosphamide, and polymyxin B-immobilized fiber column direct hemoperfusion (PMX-DHP) were 403 (73.4%), 318 (57.9%), and 78 (14.2%), respectively. All these treatments were given significantly more frequently to the patients with DM compared with those with PM. The uses of other treatment options were much less frequent. The median periods after hospitalization when methylprednisolone pulse therapy, calcineurin inhibitors, mechanical ventilation, intravenous cyclophosphamide, and PMX-DHP were initiated and in-hospital death occurred among patients with DM were 2, 4, 7, 8, 17, and 36 days, respectively. In-hospital mortality was significantly higher in patients with DM than in those with PM (76.6% versus 56.8%; P < 0.001). CONCLUSION: The mortality of patients with myositis-associated severe ILD who require mechanical ventilation is extremely high despite aggressive and prompt interventions.
引用
- Furuya H, Nakajima M, Ikeda K, et al. Prognosis and Treatment of Myositis-Associated Severe Interstitial Lung Disease: A Descriptive Study Using a Nationwide Inpatient Database in Japan. Arthritis Care Res (Hoboken). 2022. PMID: 33973401. doi:10.1002/acr.24646
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。